High Mobility Group Box Chromosomal Protein-1 Induces Myofibroblast Differentiation and Extracellular Matrix Production via RAGE, p38, JNK and AP-1 Signaling Pathways in Nasal Fibroblasts
Authors:
- 24 February 2021
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 35 (6) , 774-780
Abstract
Chronic rhinosinusitis is involved in myofibroblast differentiation and extracellular matrix (ECM) accumulation. High mobility group box chromosomal protein 1 (HMGB-1) is known to stimulate lung fibroblast to produce ECM in lung fibrosis. The aim of this study was to investigate whether HMGB-1 induces myofibroblast differentiation and ECM production in nasal fibroblasts and to identify the signal pathway. Human nasal fibroblasts were cultured. After stimulation with HMGB-1, expressions of α-smooth muscle actin (α-SMA) and fibronectin were determined by real-time PCR and western blot. Total collagen was measured by Sircol assay. To investigate signal pathway, various signal inhibitors and RAGE siRNA were used. HMGB-1 increased α-SMA and fibronectin in mRNA and protein levels. It also increased collagen production. RAGE siRNA inhibited HMGB-1-induced α-SMA and fibronectin, and production of collagen. Furthermore, the inhibitors of RAGE downstream molecules such as p38, JNK and AP-1 also blocked the HMGB-1-induced effects. HMGB-1 induces myofibroblast differentiation and ECM production in nasal fibroblast, which is mediated by RAGE, p38, JNK and AP-1 signal pathway. These results suggest that HMGB-1 may play an important role in tissue remodeling during chronic rhinosinusitis progression.Keywords
This publication has 13 references indexed in Scilit:
- High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- High Mobility Group Box 1 Induced Human Lung Myofibroblasts Differentiation and Enhanced Migration by Activation of MMP-9PLOS ONE, 2015
- Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathwayToxicology and Applied Pharmacology, 2015
- Level of secreted HMGB1 correlates with severity of inflammation in chronic rhinosinusitisThe Laryngoscope, 2015
- Expression of the Receptor for Advanced Glycation End Products, a Target for High Mobility Group Box 1 Protein, and its Role in Chronic Recalcitrant Rhinosinusitis with Nasal PolypsArchivum Immunologiae et Therapiae Experimentalis, 2014
- Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polypsInternational Forum of Allergy & Rhinology, 2014
- Increased Expression of High-Mobility Group Protein B1 in Chronic RhinosinusitisAmerican Journal of Rhinology & Allergy, 2013
- Exogenous high‐mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF‐β/Smad signaling pathwayJournal of Cellular Biochemistry, 2013
- Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancerExpert Opinion on Therapeutic Targets, 2010
- The Role of High Mobility Group Box1 in Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2008